May 18, 2017

FDA ORA Realignment Adds New BIMO Office

The FDA’s Office of Regulatory Affairs realignment, which replaces the organization’s old management structure based on geographic regions with one that is program-based, includes a consolidated Office of Bioresearch Monitoring Operations (OBIMO),...

You must be a subscriber to access this information. If you are a subscriber, please login. Not Yet A Subscriber? Click here to register for a free trial or contact Client Services at 800-677-3789 to activate your subscription.

Feedback Form
Leads to Insight